Induction of protective immunity against experimental amebic abscess of the liver (EAAL) using the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica: A preliminary report

Archives of Medical Research

Volumn 31, Issue 4, 2000, Pages S110-S111

  López Osuna, Martha ^a   Cárdenas, Guadalupe ^a   Isario, José ^a   Arellano, Jorge ^a   Fernández Diez, Jorge ^b   Isibasi, Armando ^c   Kretschmer, Roberto ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b HOSPITAL DE ONCOLOGÍA   (Mexico)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Entamoeba histolytica; MLIF vaccination (immunization)

Indexed keywords

AMEBIASIS VACCINE; FREUND ADJUVANT; KEYHOLE LIMPET HEMOCYANIN; MONOCYTE LOCOMOTION INHIBITORY FACTOR; OLIGOPEPTIDE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENTAMOEBA HISTOLYTICA; HOST RESISTANCE; IMMUNIZATION; LIVER AMEBIASIS; MALE; MONOCYTE; NONHUMAN; VACCINATION;

ANIMALS; ENTAMOEBA HISTOLYTICA; GERBILLINAE; LIVER ABSCESS, AMEBIC; MALE; PROTOZOAN PROTEINS;

EID: 0033744986     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(00)00168-5     Document Type: Article

References (3)

1. Inhibition of human monocyte locomotion by products of axenically grown Entamoeba histolytica
2. A new mechanism involving cyclic tautomers for the reaction with nucleophils of the water-soluble peptide coupling reagent 1-ethyl-3-(dimethylamino) propyl)-carbodiimide (EDC)
3. Antigen induced eosinophilia protects gerbils (Meriones unguiculatus) against experimental amebic abscess of the liver